Patent · US Active

Substituted asymmetric ureas as modulators of ghrelin receptor activity

US10577384B2 · kind B2 · utility

2Cited by

2References

15Claims

0Family size

Assignee

Helsinn Healthcare SA · CH

Inventors

Claudio Giuliano · Como, IT
Silvina Garcia Rubio · Princeton, US
Antoine Daina · Lausanne, CH
Angelo Guainazzi · Iselin, US
Claudio Pietra · Como, IT

Key dates

Filing date	Feb 6, 2018
Grant date	Mar 3, 2020
Priority date	—
Expiry date	Feb 6, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the ghrelin receptor. The compounds have the general Formula I: or pharmaceutically acceptable salts thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.